These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 405861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Subacute myelo-optico-neuropathy (SMON) following pneumonitis. Serologic confirmation three and a half years after death.
    Chambers CH, Straumfjord JV, Clowry LJ, Nishibe Y, Inoue YK.
    Am J Clin Pathol; 1976 Sep; 66(3):531-6. PubMed ID: 961632
    [Abstract] [Full Text] [Related]

  • 5. [Epidemiologic investigation on the etiology of subacute myelo-optic-neuropathy].
    Kono R.
    Saishin Igaku; 1971 Oct; 26(10):1875-83. PubMed ID: 4942696
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subacute myelo-optic neuropathy. A toxic or a viral etiology?
    Otte G, De Coster W, Thiery E, De Reuck J, Vander eecken H.
    Acta Neurol Belg; 1976 Oct; 76(5-6):331-4. PubMed ID: 137650
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between infection and subacute myelo-optico-neuropathy with abdominal symptoms (SMON) in the prevalent district. 1. Relationship between disease outbreak and the result of the examination of drinking water in the Ibara District, Okayama Prefecture (epidemiological study of SMON. 2)].
    Ogata M, Jitsunari F, Shimada Y.
    Nihon Densenbyo Gakkai Zasshi; 1969 Aug; 43(5):113-9. PubMed ID: 4981516
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Epidemiological and etiological study on subacute myelo-optico-neuropathy with abdominal symptoms].
    Hanakago R, Sugiyama T.
    Saishin Igaku; 1969 Dec; 24(12):2431-9. PubMed ID: 5363402
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Joint discussion on SMON].
    Kono R, Inoue Y, Hinuma Y, Takahashi M, Nagata I.
    Nihon Rinsho; 1971 Feb; 29(2):775-7. PubMed ID: 5102711
    [No Abstract] [Full Text] [Related]

  • 15. Halogenated oxyquinoline derivatives and neurological syndromes.
    Shimada Y, Tsuji T, Igata A, Steinitz H.
    Lancet; 1971 Jul 03; 2(7714):41-3. PubMed ID: 4103679
    [No Abstract] [Full Text] [Related]

  • 16. A nephropathy in the genesis of S.M.O.N.?
    de Crousaz G, Voumard C, de Werra P.
    Lancet; 1973 Feb 17; 1(7799):378. PubMed ID: 4121977
    [No Abstract] [Full Text] [Related]

  • 17. Subacute myelo-optico-neuropathy, a new neurological disease prevailing in Japan.
    Kono R.
    Jpn J Med Sci Biol; 1971 Aug 17; 24(4):195-216. PubMed ID: 4944758
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Etiology of SMON--from the viewpoint of infection].
    Kono R.
    Shinkei Kenkyu No Shimpo; 1971 Aug 17; 15(2):507-9. PubMed ID: 5106857
    [No Abstract] [Full Text] [Related]

  • 20. Letter: The S.M.O.N. virus theory.
    Kono R.
    Lancet; 1975 Aug 23; 2(7930):370-1. PubMed ID: 51180
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.